You can accept or revoke the cookies used on this website at any time with the selection below or by adjusting your cookie settings. For complete details about our cookies, see our Cookie Policy.
dPCR LNA Mutation Assays
For detecting specific DNA sequence mutations related to cancer and oncogenesis
Duplex assay design detects mutated and wild-type sequences
Choice of FAM + HEX or Atto 550 + ROX fluorescent dye combinations
LNA-enhanced primers and probes increase assay specificity and sensitivity
Wet-lab tested dPCR assays available for more than 200 targets
Suitable for use with circulating tumor DNA, liquid biopsy, FFPE and other tissue samples
Digital PCR (dPCR) is a powerful technique that detects and quantifies ultra-rare mutations in a high background of wild-type cfDNA down to 0.1% variant allele frequency. Here, we describe end-to-end manual and automated workflows that enable accurate detection and absolute quantification of ultra-rare PIK3CA variants in cfDNA using the QIAcuity Digital PCR System.